Wu, En-Ling <br/><br/>
Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia.  [electronic resource] 

 -  JAMA pediatrics  Jan 2013 
 - 32-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6211 
<br/><br/><label>Standard No.: </label>10.1001/jamapediatrics.2013.419  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Biomarkers--blood<br/>Blood Glucose--metabolism<br/>Child<br/>Cohort Studies<br/>Computer Simulation<br/>Cost-Benefit Analysis<br/>Diabetes Mellitus, Type 2--blood<br/>Glucose Tolerance Test--economics<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hyperglycemia--blood<br/>Mass Screening--economics<br/>Medicare<br/>Models, Economic<br/>Prediabetic State--blood<br/>United States